☰ Accessibility
Market-View-Feature-Image

View on market: Volatility persists, eagerly searching for growth:

US equity futures edged lower after President Donald Trump said discussions with Democrats on health care would take place only after the government reopens. European futures traded slightly higher during Asian hours. In Asia, Japanese shares continued to rise as the election of pro-stimulus leader Sanae Takaichi weakened the yen and lifted long-term bond yields. Australian stocks declined, while markets in China and South Korea remained closed. On Wall Street, stocks ended at record highs, led by gains in technology companies. Investors looked past the ongoing government shutdown and focused on optimism surrounding a large infrastructure deal that signaled continued strength in artificial intelligence investment. The S&P 500 and Nasdaq posted further advances, marking a steady upward trend, while the Dow slipped slightly. In India, domestic markets extended their winning streak, closing higher for a third straight session, supported by strong investor sentiment and buying in major sectors.

Economic Calendar:

  • USD: Import and Export Data on 07th October 2025.
  • IND: Foreign Reserves USD on 10th October 2025.
  • USD: Crude Oil Inventories on 08th October 2025.
  • IND CPI (Sep) on 13th October 2025.

IPO Watch:

Company Open Close Price (Rs/-) View
Tata Capital Ltd. Oct 6th Oct 8th 310-326 May Apply
LG Electr India Ltd. Oct 7th Oct 9th 1080-1140 Apply

Brokerage Radar:

MORGAN STANLEY ON TRENT:

Target Rs 6359 Recommendation Overweight, Q2: Notable Miss, Standalone revenues grew 17% YoY, lower than MS estimate of a 25% rise, Westside had 13 net new store openings, the highest in the past five years.

CITI ON INDIGO:

Target Rs 7100 Recommendation Buy, Demand outlook remains positive for the industry, with moderation in Q2, Moderation owing more to lower supply rather than weak demand, IndiGo is focusing on international routes (including long-haul).

KOTAK SECURITIES ON LTIMINDTREE:

Target Rs 5000 Recommendation Reduce, Announced its largest-ever digital transformation deal (>US$450 mn) with a global entertainment leader, The deal has a balance between renewal and new component, New CEO’s sales execution rigor is driving a good conversion of pipeline into deals.

GOLDMAN SACHS ON BSE:

Target Rs 2220 Earlier Target Rs 2250 Recommendation Neutral, NSE has become aggressive in getting back lost market share from BSE, Lot size reduction brings the contract sizes of BSE’s Sensex and NSE’s Nifty 50 closer, Thereby narrowing BSE’s advantage of lower traded premium per contract on index options.

International Markets:

U.S & Europe:

Particulars     06th  Oct   Chg. Chg.(%)
Nasdaq 22,941.67 161.16 0.71
Dow 46,694.97 -63.31 -0.14
FTSE 9,479.14 -12.11 -0.13
CAC 7,971.78 -109.76 -1.38
DAX 24,378.29 -0.51 00
Dow Fut.* 46,634.58 -60.39 -0.13

*As per 07th October.

Asian markets:

Particulars   07th  Oct Chg. Chg.(%)
GIFT Nifty                  25,189.50 4.10 0.02
Nikkei 48,291.00 298.24 0.62
Straits Times 4,458.07 36.36 0.82
Hang Seng** 26,957.77 -183.15 -0.68
Shanghai**                         3,882.78 20.25 0.52

Stocks strong on Chart:

Index F&O Cash
SBIN HDFCAMC RALLIS INDIA
HDFC BANK BRITANNIA CEAT
ICICI BANK DABUR BEML
ONGC PFC MAX ESTATE
RIL ICICIGI NIPPON AMC
BEL RECLTD MINDACORP

Commodities & Currency:

Particulars Current Price Chg.(%)
USD/INR 88.719 0.02
Brent 65.66 0.29
Gold 120,325 0.06
Silver 147,600 0.05

FIIs & DIIs:

Particulars       06th Oct        03rd Oct
FIIs                          -313.77    -1,583.37
DIIs 5,036.39 489.76

News Updates:

PNC Infratech: Has received the appointed date for two of its projects from the National Highways Authority of India.
HCL Technologies Has joined the MIT Media Lab in the US to collaborate on artificial intelligence research.
Zydus Lifesciences: Has received approval from Health Canada for Liothyronine tablets, used in the treatment of hypothyroidism.
Aster DM Healthcare: Has received no-objection letters from BSE and NSE regarding its proposed scheme of merger with Quality Care India.
Brigade Enterprises: Has signed a joint development agreement for premium residential projects in Chennai, with an estimated gross development value of Rs 1,000 crore.
LTIMindtree: Has signed a multi-year deal with a global entertainment company.
Havells India: It’s subsidiary, Havells International, will acquire a 20% stake in Salesmark Ventures. Post-acquisition, Havells HVAC will become a wholly-owned subsidiary of Havells International.
Coal India: Has signed a pact with Chhattisgarh Mineral Development Corporation for exploration of critical minerals.
Oil India: Has signed an agreement with Mahanagar Gas to explore opportunities in the liquefied natural gas value chain.
Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 214 

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

  • all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
  • No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale. Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

  1. Reports
  2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
  • EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
  • EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
        1. Compensation
    • EWL or its associates have not received any compensation from the subject company in the past twelve months;
    • EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
  • EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
  • EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
  • EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research
  1. In respect of Public Appearances
  • EWL or its associates have not received any compensation from the subject company in the past twelve months;
  • The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL